questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of including metachromatic leukodystrophy in the newborn blood spot test.
answerText: The UK National Screening Committee (UK NSC) considered newborn screening for metachromatic leukodystrophy (MLD) in 2023. At that time, it concluded that the available evidence on screening test accuracy and cost-effectiveness, though limited, warranted f...
heading: Metachromatic Leukodystrophy: Screening